http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011011376-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3acf20930acae4990c5805854202c35e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62fe340a7025ff901d6458ae358d9efc
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-12
filingDate 2010-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b56eeee08d9cb72d456b42cdda58eb5
publicationDate 2011-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2011011376-A3
titleOfInvention Methods for the preparation and use of aqueous solutions of magnesium valproate hydrate and l-carnitine
abstract The present invention relates to methods for preparing liquid valproate compositions comprising solutions of a magnesium valproate and L-carnitine in water and administering said compositions to a subject in need of treatment with valproate and L-carnitine. The compositions of the invention are particularly useful treatments for infants, young children, women of child-bearing age, the aging, institutionalized patients, and patients having dysphagia who are receiving valproate treatment and are at high risk for valproate-related L-carnitine deficiency and cellular dysfunction and hepatotoxicity related thereto.
priorityDate 2009-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0637449-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7482486-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5180850-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6753349-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008234378-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID147515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3121
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411138
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87186185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226450379
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226450378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227255608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57506887

Total number of triples: 38.